Premier Biomedical Inc
OOTC:BIEICapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Ivan Mendez
- Full Time Employees
- 4
- Sector
- Health technology
- Industry
- Pharmaceuticals: other
- Address
- PO Box 25 El Centro PA United States 16133
- IPO Date
- Feb 23, 2012
- Website
- premiergrapheneinc.com
- Similar Companies
- Business
- Premier Biomedical, Inc. (BIEI) develops and commercializes innovative biomedical technologies and therapies focused on cancer treatment, immunotherapy, and regenerative medicine. The company offers a portfolio of proprietary platforms including targeted cancer therapies such as chemophase technology for controlled drug delivery; immunotherapy products like EndoVaccine, a dendritic cell-based cancer vaccine; and regenerative solutions including stem cell technologies for tissue repair and anti-aging applications. These products target oncologists, hospitals, clinics, and research institutions primarily in the United States, with operations extending to clinical trials and partnerships in North America and Europe; Premier Biomedical was founded in 2012 and is headquartered in Fairfield, New Jersey. In the last two years, the company has pursued strategic expansions through clinical trial advancements for its cancer platforms, formation of research alliances with academic institutions for immunotherapy validation, and initiation of Phase I/II studies for EndoVaccine without reported major acquisitions, funding rounds, or name changes as of late 2025.
Company News
Premier Graphene Inc. and Affiliate HGI Industrial Technologies S.A.P.I. de C.V. Receive Payment for Mexican Military Purchase Order
Premier Biomedical (OTCMKTS:BIEI) Stock Price Crosses Above 50 Day Moving Average – Here’s Why
Premier Graphene Inc. (OTC: BIEI) Affiliate HGI Industrial Technologies Secures Mexican SAT Authorization to Import Firearms, Ammunition and Related Products
Short Interest in Premier Biomedical, Inc. (OTCMKTS:BIEI) Increases By 49,027.3%
Premier Biomedical (OTCMKTS:BIEI) Shares Cross Above Fifty Day Moving Average – What’s Next?
Premier Biomedical (OTCMKTS:BIEI) Share Price Crosses Above Fifty Day Moving Average – Here’s What Happened
Premier Graphene, Inc. (OTC: BIEI) and HGI Industrial Technologies Successfully Complete Second Government Contract Milestone
Premier Graphene, Inc. (OTC: BIEI) and HGI Industrial Technologies Successfully Complete Second Government Contract Milestone
Premier Graphene Inc. (BIEI) makes Down Payment for the Production of a Second SEDENA Contract
Premier Graphene Eyes Space and Aerospace Applications
Premier Graphene Inc. (OTC: BIEI) Currently Anticipates Reporting First Profitable Quarter in Company History
Premier Graphene Inc. and Affiliate HGI Industrial Technologies Secure Two New Mexican Military Contracts, Advancing Defense Revenue Strategy
Premier Graphene Expands Strategic Position Following Initial Mexico Military Contract
PRISM MediaWire – Weekly Press Release Round Up – April 20 to April 24, 2026 – Top Financial & Corporate News Highlights
Premier Graphene and JV Partners Secure Military Contract
Premier Graphene Inc., in Coordination with its Joint Venture Partners – HGI Industrial Technologies SAPI and Nevada Ballistic Armor Corp., along with other Affiliates, secured their Initial Contract with Mexico's Defense Sector
Premier Graphene Inc., Affiliate HGI Industrial Technologies S.A. de P.I. de C.V.
Premier Graphene Inc. (OTC:BIEI) Reports Progress Securing Government Contracts in Latin American Countries, Receiving a Specific Purchase Order Request from their Authorized Personnel
President Pedro Méndez of Premier Graphene Inc. (BIEI) and HGI Industrial Technologies – Presenters at the International Cannabis & Industrial Hemp Forum
Premier Graphene Inc. ($BIEI) Secures Final “COFEPRIS” Authorization Permitting its Partners to Commence Importation and Registration of CBD, CBG, and Cannabinoid Products in Mexico